| Literature DB >> 35565110 |
Vanesa Ferreres-Galán1,2, María Vicenta Navarro-Haro2,3, Óscar Peris-Baquero2,3, Silvia Guillén-Marín3, Jordi de Luna-Hermoso1, Jorge Osma2,3.
Abstract
Healthcare professionals, especially women, have shown increases in anxious-depressive symptoms as a consequence of the COVID-19 pandemic. The aim of this pilot study was to evaluate the acceptability and preliminary effectiveness of a Unified Protocol (UP) prevention program to provide emotional regulation skills to cope with stressful situations. The sample consisted of 27 nursing professionals (100% women; mean age: 45.67; SD = 7.71) working in a Spanish public hospital during COVID-19, who were randomized to an immediate treatment group (ITG, n = 13) or to a delayed treatment group (DTG, n = 14, which served as the waiting list control group and received the program 5 weeks after the ITG had received it). The program consisted of five-weekly, two-hour, UP-based group sessions. Variables related to emotional symptomatology, emotional regulation, personality, burnout, and perceived quality of life were evaluated at the following time points: pre- and post-intervention and at 1-, 3-, and 6-month follow-ups. Statistically significant between-group differences showed lower emotional exhaustion and personal accomplishment in favor of the ITG after the intervention. Regarding the effect over time for all participants who received the UP (n = 27), statistically significant reductions were observed in neuroticism, personal accomplishment, and subjective distress caused by traumatic events (-0.23 ≤ d ≤ -0.73). A statistically significant interaction "Time*Condition" was found in anxiety, with increases in the DTG. Participants showed high satisfaction with the UP. These findings show good acceptability and preliminary effectiveness of the UP to reduce the emotional impact of the pandemic in female nursing workers.Entities:
Keywords: COVID-19 pandemic; emotion regulation skills; nursing professionals; prevention; unified protocol
Mesh:
Year: 2022 PMID: 35565110 PMCID: PMC9101624 DOI: 10.3390/ijerph19095715
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1CONSORT diagram illustrating participant flow in the study. Note: ITG: Immediate treatment group; DTG: Delayed treatment group; T0: Pre-treatment; T1: Immediate treatment group post-treatment; T2: Delayed treatment group post-treatment; T3: 1-month follow-up; T4: 3-month follow-up; T5: 6-month follow-up.
Baseline socio-demographic characteristics of the sample across treatment conditions (N = 27).
| ITG ( | DTG ( | TOTAL (N = 27) | |
|---|---|---|---|
| Marital Status | |||
| Married/living with partner | 10 (76.9) | 11 (78.6) | 21 (77.8) |
| Single | 3 (23.1) | 2 (14.3) | 5 (18.5) |
| Widowed | 0 (0.0) | 1 (7.1) | 1 (3.7) |
| Occupation | |||
| Nurse | 6 (46.2) | 8 (57.1) | 14 (51.9) |
| Auxiliary nursing care technician | 7 (53.8) | 5 (35.7) | 12 (44.4) |
| Anatomic pathology technician | - | 1 (7.1) | 1 (3.7) |
| Hospital Unit | |||
| Internal Medicine B | 4 (30.8) | 4 (28.6) | 8 (29.6) |
| Internal Medicine A | 3 (23.1) | 3 (21.4) | 6 (22.2) |
| COVID-19 Surgery | 3 (23.1) | 0 (0.0) | 3 (11.1) |
| Emergencies | 0 (0.0) | 2 (14.3) | 2 (7.4) |
| COVID-19 plant | 1 (7.7) | 0 (0.0) | 1 (3.7) |
| Others | 2 (15.4) | 5 (35.6) | 7 (25.9) |
| Work experience | |||
| More than 5 years | 11 (84.6) | 13 (92.9) | 24 (88.9) |
| 2–5 years | 2 (15.4) | 1 (7.1) | 3 (11.1) |
| Virus Exposure (0 “no contact” to 10 “close contact”) | |||
| Less than 8 | 4 (30.8) | 4 (28.6) | 8 (29.6) |
| More than 8 | 9 (69.2) | 10 (71.4) | 19 (70.4) |
| 8 | 3 (23.1) | 0 (7.1) | 3 (11.1) |
| 9 | 1 (7.7) | 1 (7.1) | 2 (7.4) |
| 10 | 5 (38.5) | 9 (64.3) | 14 (51.9) |
| COVID infection | |||
| No | 10 (76.9) | 12 (85.7) | 22 (81.5) |
| Yes | 3 (23.1) | 2 (14.3) | 5 (18.5) |
| Severity of Symptoms (0 “no symptoms” to 10 “severe symptoms”) | |||
| 0 | 1 (33.3) | 1 (50.0) | 2 (40.0) |
| 2 | 1 (33.3) | 1 (50.0) | 2 (40.0) |
| 3 | 1 (33.3) | 0 (0.0) | 1 (20.0) |
| Family members infected | |||
| No | 8 (61.5) | 10 (71.4) | 18 (66.7) |
| Yes | 5 (38.5) | 4 (28.6) | 9 (33.3) |
Note: ITG: Immediate treatment group; DTG: Delayed treatment group; Internal Medicine (A, B): group of medical specialty focused on the global treatment of diseases.
Means and standard deviations of the variables over time in the immediate and delayed treatment groups. (N = 27).
| T0 | T1 | T2 | T3 | T4 | T5 | |||
|---|---|---|---|---|---|---|---|---|
| M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | |||
| Primary outcomes | DASS_Stress | ITG | 6.62 (4.52) | 4.54 (3.99) | - | 4.77 (4.04) | 5.18 (4.79) | 4.18 (3.19) |
| DTG | 7.36 (3.59) | 5.42 (2.23) | 5.29 (2.09) | 5.45 (2.66) | 5.17 (2.44) | 7.17 (3.19) | ||
| DASS_Anxiety | ITG | 4.00 (3.56) | 2.15 (1.95) | - | 1.85 (2.34) | 2.27 (3.90) | 1.36 (1.96) | |
| DTG | 3.50 (1.7) | 2.92 (2.15) | 3.00 (2.83) | 2.18 (1.72) | 1.83 (2.21) | 4.17 (2.86) | ||
| DASS_Depression | ITG | 5.85 (5.8) | 3.69 (5.02) | - | 3.08 (3.57) | 4.09 (4.61) | 4.27 (4.34) | |
| DTG | 5.00 (4.76) | 2.67 (1.92) | 4.14 (3.7) | 2.70 (2.87) | 3.08 (2.31) | 3.67 (2.77) | ||
| Secondary outcomes | DERS | ITG | 58.92 (17.54) | 54.23 (18.21) | - | 51.54 (15.69) | 50.55 (14.47) | 49.36 (13.84) |
| DTG | 56.57 (14.85) | 55.75 (11.14) | 55.23 (12.06) | 49.4 (9.99) | 55.27 (15.51) | 53.83 (12.08) | ||
| Neuroticism | ITG | 21.77 (9.64) | 21.46 (8.25) | - | 18.17 (8.70) | 18.00 (9.19) | 18.00 (9.30) | |
| DTG | 21.79 (4.64) | 19.00 (5.77) | 19.36 (5.53) | 19.5 (5.10) | 19.5 (5.65) | 19.25 (4.96) | ||
| Extraversion | ITG | 25.46 (5.09) | 26.92 (5.92) | - | 28.42 (6.99) | 28.9 (5.57) | 28.00 (6.45) | |
| DTG | 24.21 (6.96) | 25.92 (4.89) | 26.00 (6.8) | 27.67 (7.78) | 26.67 (7.02) | 27.08 (6.52) | ||
| MBI_Emotional Exhaustion | ITG | 11.00 (9.21) | 9.69 (6.97) | - | 10.15 (7.36) | 11.36 (5.73) | 13.45 (9.70) | |
| DTG | 16.00 (11.64) | 17.17 (10.17) | 16.21 (7.68) | 15.3 (8.65) | 14.18 (8.81) | 17.33 (11.11) | ||
| MBI_Depersonalization | ITG | 5.85 (4.24) | 5.69 (3.84) | - | 5.08 (4.09) | 5.45 (5.35) | 5.55 (4.18) | |
| DTG | 4.79 (5.18) | 5.33 (3.87) | 4.57 (3.80) | 2.91 (2.39) | 3.42 (3.32) | 3.92 (4.78) | ||
| MBI_Personal accomplishment | ITG | 40.92 (4.92) | 35.15 (6.57) | - | 38.23 (6.37) | 40.00 (3.9) | 36.82 (5.51) | |
| DTG | 38.79 (5.92) | 40.42 (5.07) | 38.57 (7.90) | 40.6 (4.43) | 39.18 (6.6) | 37.42 (6.69) | ||
| IESR_Intrusion | ITG | 23.15 (13.63) | 19.85 (13.56) | - | 15.33 (13.25) | 16.73 (12.64) | 14.27 (11.88) | |
| DTG | 18.5 (9.59) | 20.33 (9.16) | 19.85 (8.22) | 18.45 (13.02) | 15.42 (8.51) | 14.5 (6.97) | ||
| IESR_Avoidance | ITG | 15.08 (7.58) | 13.08 (6.60) | - | 11 (6.78) | 11.36 (6.87) | 9.82 (7.21) | |
| DTG | 11.21 (5.94) | 13.75 (6.31) | 12.79 (4.12) | 10.18 (6.21) | 11.58 (5.43) | 9.75 (4.65) | ||
| EuroQol | ITG | 74.23 (18.13) | 76.54 (17.37) | - | 82.67 (13.61) | 79.55 (15.92) | 81.36 (16.45) | |
| DTG | 77.86 (7.77) | 78.00 (7.51) | 83.75 (7.72) | 86.36 (5.52) | 78.17 (24.48) | 78.33 (14.51) | ||
Note: ITG: Immediate treatment group; DTG: Delayed treatment group; T0: Pre-treatment; T1: Immediate treatment group post-treatment; T2: Delayed treatment group post-treatment; T3: 1-month follow-up; T4: 3-month follow-up; T5: 6-month follow-up; DASS_Stress, DASS_Anxiety, and DASS_Depression: Depression, Anxiety, and Stress Scales dimensions; DERS: Difficulties in Emotion Regulation Scale; Neuroticism and Extraversion: NEO-Five-Factor Personality Inventory dimensions; MBI_Emotional Exhaustion, MBI_Depersonalization, and MBI_Personal accomplishment: Maslach Burnout Inventory dimensions; IESR_Intrusion and IESR_Avoidance: Impact of Event Scale-Revised; and EuroQol: European Quality of Life.
Main effects of the linear mixed models.
| Time | Condition | Time*Condition | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| |
| DASS_Stress | 1.04 | 0.390 | 0.41 | 0.02 | 0.895 | 0.18 | 1.59 | 0.184 | 0.50 |
| DASS_Anxiety | 1.94 | 0.110 | 0.56 | 0.38 | 0.541 | 0.25 |
|
| 0.71 |
| DASS_Depression | 1.26 | 0.290 | 0.45 | 0.99 | 0.328 | 0.40 | 1.94 | 0.110 | 0.56 |
| DERS | 2.36 | 0.060 | 0.61 | 0.01 | 0.917 | 0.04 | 0.97 | 0.425 | 0.39 |
| Neuroticism |
|
| 0.64 | 0.31 | 0.583 | 0.22 | 1.61 | 0.179 | 0.51 |
| Extraversion | 2.09 | 0.089 | 0.58 | 0.00 | 0.992 | 0.00 | 0.33 | 0.859 | 0.23 |
| MBI_Emotional Exhaustion | 1.19 | 0.321 | 0.44 | 3.03 | 0.093 | 0.70 | 0.62 | 0.653 | 0.31 |
| MBI_Depersonalization | 0.80 | 0.527 | 0.36 | 1.70 | 0.204 | 0.52 | 0.20 | 0.939 | 0.18 |
| MBI_Personal accomplishment |
|
| 0.80 | 0.52 | 0.476 | 0.29 | 1.14 | 0.343 | 0.43 |
| IESR_Intrusion |
|
| 0.89 | 0.29 | 0.597 | 0.22 | 1.26 | 0.290 | 0.45 |
| IESR_Avoidance |
|
| 0.88 | 0.39 | 0.535 | 0.25 | 0.10 | 0.983 | 0.13 |
| EuroQol | 1.88 | 0.121 | 0.55 | 0.43 | 0.520 | 0.26 | 0.64 | 0.638 | 0.32 |
Note: OASIS: DASS_Stress, DASS_Anxiety, and DASS_Depression: Depression, Anxiety, and Stress Scales dimensions; DERS: Difficulties in Emotion Regulation Scale; Neuroticism and Extraversion: NEO-Five-Factor Personality Inventory dimensions; MBI_Emotional Exhaustion, MBI_Depersonalization, and MBI_Personal accomplishment: Maslach Burnout Inventory dimensions; IESR_Intrusion and IESR_Avoidance: Impact of Event Scale-Revised; and EuroQol: European Quality of Life; p-values < 0.05 are shown in bold.
Post hoc analyses for the Time*Condition.
| Main Effects |
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | T4 | T5 |
|
| Pre-T-to-Post-T | Post-T-to-6-MFU | Pre-T-to-6-MFU | ||
| M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | |||||||
| DASS_Anxiety | ITG | 4.00 (3.56) | 2.15 (1.95) | - | 1.85 (2.34) | 2.27 (3.90) | 1.36 (1.96) | 2.20 | 0.084 | −0.64 | −0.40 | −0.92 |
| DTG | 3.50 (1.7) | 2.92 (2.15) | 3.00 (2.83) | 2.18 (1.72) | 1.83 (2.21) | 4.17 (2.85) |
|
| 0.03 | 0.41 | 0.49 | |
Note: ITG: Immediate treatment group; DTG: Delayed treatment group; T0: Pre-treatment; T1: Immediate treatment group post-treatment; T2: Delayed treatment group post-treatment; T3: 1-month follow-up; T4: 3-month follow-up; T5: 6-month follow-up; DASS_Anxiety: Depression, Anxiety, and Stress Scales; p-values < 0.05 are shown in bold.